Nagourney Cancer Institute

Nagourney Cancer Institute is a small, fully accredited laboratory located in Long Beach, California. Founded in 1995 by Dr. Robert Nagourney, the institute specializes in personalized cancer treatment through its unique Ex Vivo Analysis of Programmed Cell Death (EVA-PCD) assay. The EVA-PCD assay is a state-of-the-art functional profiling test that analyzes a patient's tumor biology in real-time to determine the most effective and least toxic treatment options. This analysis considers a range of therapies, identifying which drugs induce cancer cell death. Nagourney Cancer Institute serves both individual patients and pharmaceutical companies. For patients, the institute offers personalized treatment guidance based on the EVA-PCD results. For pharmaceutical companies, the institute provides drug efficacy testing for various human tumor diagnoses. Patients interested in learning more about their specific case can contact Nagourney Cancer Institute's Patient Relations Representatives at 1-800-542-4357. Dr. Nagourney, a practicing hematologist/oncologist, is also available for clinical consultations to assist patients in making informed treatment decisions.